Larry Merizalde, based in Shanghai, China, is currently a Chief Executive Officer China at Aspen Pharma Group, bringing experience from previous roles at Teva Pharmaceuticals. Larry Merizalde holds a Advanced Management Program (AMP 200) @ Harvard Business School. With a robust skill set that includes Pharmaceutical Industry, Medical Devices, Business Development, Emerging Markets, Mergers and more, Larry Merizalde contributes valuable insights to the industry. Larry Merizalde has 2 emails on RocketReach.